Section of Endocrine Surgery, Department of Surgery, Indiana University, 545 Barnhill Drive EH 537, Indianapolis, IN 46202, USA.
Division of Endocrine Surgery, Department of Surgery, University of Wisconsin-Madison, 600 Highland Avenue, CSC K4/738, Madison, WI 53792-7375, USA.
Surg Clin North Am. 2019 Aug;99(4):599-610. doi: 10.1016/j.suc.2019.04.003. Epub 2019 May 13.
Although the incidence of thyroid cancer is increasing, survival remains unchanged. Due to concern for overtreatment, surgical management of thyroid cancer has evolved. Papillary thyroid microcarcinoma measuring 1 cm or smaller are considered very low risk and can be managed with either thyroid lobectomy or active surveillance. Total thyroidectomy is no longer recommended for these cancers unless there is evidence of metastasis, local invasion, or aggressive disease. Recommendations for low-risk differentiated thyroid cancer measuring 1 cm to 4 cm remain controversial. This article explores the controversies over the extent of surgery for patients with very low-risk and low-risk differentiated thyroid cancer.
尽管甲状腺癌的发病率在不断增加,但存活率仍保持不变。由于担心过度治疗,甲状腺癌的手术治疗方式也在不断发展。直径 1 厘米或更小的甲状腺乳头状微小癌被认为是极低风险的,可以通过甲状腺叶切除术或主动监测来治疗。除非有转移、局部侵犯或侵袭性疾病的证据,否则不再建议对这些癌症进行全甲状腺切除术。对于直径 1 至 4 厘米的低危分化型甲状腺癌,推荐的手术范围仍存在争议。本文探讨了极低危和低危分化型甲状腺癌患者手术范围的争议。